Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Cardiac Troponin Market From 2025 To 2029?

Recently, the cardiac troponin market has seen accelerated expansion. The market value will rise from its $3.85 billion worth in 2024 to $4.24 billion by 2025, growing at a compound annual growth rate (CAGR) of 10.3%. The significant expansion in the historic period can be linked to several factors including an increase in cardiovascular illnesses, heightened awareness and early recognition of heart-related ailments, development of healthcare facilities in emerging economies, a surge in the older population, and the launch of highly sensitive cardiac troponin tests.

The market size for cardiac troponin is set to witness substantial growth in the coming years, reaching $6.29 billion in the year 2029 with a compound annual growth rate (CAGR) of 10.3%. This anticipated growth can be credited to the increasing prevalence of cardiovascular issues related to lifestyle choices, along with the spread of cardiac care facilities, growing preference for at-home health care, advancements in personalised medicine, and the need for more efficient, economical diagnostic alternatives. Key trends expected during this forecast period involve the use of machine learning for cardiac care data analysis, exploring the use of cardiac troponin in areas other than just acute coronary syndromes, progress with multiplex testing for simultaneous biomarker investigations, the search for new biomarkers in conjunction with troponin, and advances in personalised medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18986&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Cardiac Troponin Market?

The escalating occurrences of heart-related health issues are outlined as a significant force projected to spur the expansion of the cardiac troponin market. Various cardiovascular diseases fall under the category of heart-related conditions, for example, coronary artery disease, heart failure, arrhythmias, and congenital heart defects, all of which impact the heart’s structure and functionality. Factors like growing older populations, sedentary lifestyles, poor eating habits, and escalating instances of obesity and hypertension are fuelling the rise in heart-related conditions. Cardiac troponin plays a pivotal role in identifying these heart-related conditions as it acts as an extremely sensitive biomarker that can detect damage to the heart muscle, especially in situations around heart attacks and other cardiac incidents. To illustrate, the Report on Registration of Births and Deaths 2023 from the Registry of Births and Deaths, Immigration and Checkpoints Authority, Singapore, and the Ministry Of Health has noted that ischemic heart diseases have been responsible for a total of 5,302 deaths, showing a marginal growth from the 5,290 death cases logged in 2022. Therefore, the escalating occurrences of heart-related health issues will catalyze the expansion of the cardiac troponin market.

Which Key Market Segments Comprise the Cardiac Troponin Market and Drive Its Revenue Growth?

The cardiac troponinmarket covered in this report is segmented –

1) By Type: Troponin I; Troponin T

2) By Location Of Testing: Laboratory Setting; Point Of Care (Poc) Testing

3) By Application: Acute Coronary Syndrome; Myocardial Infraction; Congestive Heart Failure; Other Applications

4) By End User: Hospitals; Diagnostic Centers; Homecare Setting; Other End Users

Subsegments:

1) By Troponin I: Cardiac Troponin I (cTnI); Muscle Troponin I

2) By Troponin T: Cardiac Troponin T (cTnT); Skeletal Troponin T

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18986&type=smp

Which Areas Are Leading Regions in the Cardiac Troponin Market Expansion Across the Globe?

North America was the largest region in the cardiac troponin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theCardiac Troponin Market Direction?

Prominent corporations in the cardiac troponin market are concentrating on the advancement of novel technologies, such as human serum-based quality control, to provide accurate and dependable high-sensitivity troponin tests through multi-analyte controls. The application of human serum-based quality control in cardiac troponin tests aids in ascertaining the precision and dependability of the tests as it employs human serum with identified troponin concentrations to evaluate the assay’s performance. For example, Bio-Rad Laboratories, Inc., a biotechnology research entity based in the US, rolled out Cardiac Advance in May 2023. This is a four-tier, multi-analyte quality control engineered explicitly for high-sensitivity troponin testing. These controls, designed for high-sensitivity troponin testing, are liquid, human-serum-based products offered in InteliQ 3-mL vials, Liquichek 3-mL standard, and 2.5-mL compact tubes. These controls incorporate 10 cardiac analytes, among them troponin, CK-MB, BNP/proBNP, and myoglobin, and they are compatible with both Siemens and Roche testing platforms. The controls are accessible in the U.S., Europe, and chosen Asian markets.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiac-troponin-global-market-report

How Is the Cardiac Troponin Market Conceptually Defined?

Cardiac troponin refers to a group of proteins found in heart muscle (myocardium) that help regulate heart contractions. Troponins are part of the muscle fiber proteins that control the interaction between actin and myosin, which are essential for muscle contraction. It acts as a biomarkers which is used to diagnose heart injury, especially heart attacks.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18986

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model